111 related articles for article (PubMed ID: 7009093)
1. [Adjuvant immunotherapy using polyadenylic acid and polyuridylic acid (Poly A., Poly U.) in operable carcinoma of the breast (author's transl)].
Lacour F; Lacour J; Spira A; Michelson M; Petit JY; Delage G; Contesso G; Merlin-Nahon E; Sarrazin D; Viguier J
Chirurgie; 1980 Nov; 106(9):737-43. PubMed ID: 7009093
[No Abstract] [Full Text] [Related]
2. [Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].
Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
Chirurgie; 1984; 110(4):418-24. PubMed ID: 6389040
[No Abstract] [Full Text] [Related]
3. [Trials of (poly A. poly U) adjuvant immunotherapy in breast cancer treatment].
Lacour J; Lacour F; Spira A; Delage G; Michelson AM
Bull Cancer; 1974; 61(2):275-80. PubMed ID: 4465011
[No Abstract] [Full Text] [Related]
4. Clinical trials using polyadenylic-polyuridylic acid as an adjuvant to surgery in treating different human tumors.
Lacour J
J Biol Response Mod; 1985 Oct; 4(5):538-43. PubMed ID: 3908619
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic trial of Poly(A).Poly(U) adjuvant immunotherapy in operable cancer of the breast. Long-term results].
Lacour J; Lacour F; Ducot B; Spira A; Michelson M; Petit JY; Sarrazin D; Contesso G
Chirurgie; 1988; 114(6):516-23. PubMed ID: 3067998
[No Abstract] [Full Text] [Related]
6. Polyadenylic-polyuridylic acid as adjuvant in the treatment of operable breast cancer: recent results.
Lacour J; Lacour F; Ducot B; Spira A; Michelson M; Petit JY; Sarrazin D; Contesso G
Eur J Surg Oncol; 1988 Aug; 14(4):311-6. PubMed ID: 3044833
[TBL] [Abstract][Full Text] [Related]
7. A new adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer.
Lacour F; Lacour J; Spira A; Michelson M; Delage G; Petit JY; Viguier J
Recent Results Cancer Res; 1982; 80():200-6. PubMed ID: 7036283
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial.
Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
Br Med J (Clin Res Ed); 1984 Feb; 288(6417):589-92. PubMed ID: 6421391
[TBL] [Abstract][Full Text] [Related]
9. A phase I clinical tolerance study of polyadenylic-polyuridylic acid in cancer patients.
Ducret JP; Caillé P; Sancho Garnier H; Amiel JL; Michelson M; Hovanessian AG; Youn JK; Lacour F
J Biol Response Mod; 1985 Apr; 4(2):129-33. PubMed ID: 3998763
[TBL] [Abstract][Full Text] [Related]
10. Re: perioperative acute phase response modification by polyadenylic-polyuridylic acid.
Leris AC; Mokbel K
Eur J Surg Oncol; 2000 Mar; 26(2):196-7. PubMed ID: 10744948
[No Abstract] [Full Text] [Related]
11. Polyadenylic-polyuridylic acid plus locoregional radiotherapy versus chemotherapy with CMF in operable breast cancer: a 14 year follow-up analysis of a randomized trial of the Fédération Nationale des Centres de Lutte contre le Cancer (FNCLCC).
Laplanche A; Alzieu L; Delozier T; Berlie J; Veyret C; Fargeot P; Luboinski M; Lacour J
Breast Cancer Res Treat; 2000 Nov; 64(2):189-91. PubMed ID: 11194454
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of natural killer cell activity and 2-5A synthetase in operable breast cancer patients treated with polyadenylic; polyuridylic acid.
Hovanessian AG; Youn JK; Buffet-Janvresse C; Riviere Y; Michelson M; Lacour J; Lacour F
Cancer; 1985 Jan; 55(2):357-62. PubMed ID: 2578083
[TBL] [Abstract][Full Text] [Related]
13. The age-dependent efficacy of polyadenylic-polyuridylic acid therapy upon the development of spontaneous leukemia in AKR mice.
Drake WP; Pendergrast WJ; Kramer RE; Mardiney MR
Cancer Res; 1976 Mar; 36(3):1172-5. PubMed ID: 1253174
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant effect of polyadenylic.polyuridylic acid on antibody production of recombinant hepatitis B surface antigen in mice.
Park SJ; Kim WH; Han KH; Chon CY; Hahm KB; Moon YM; Kang JK; Park IS; Youn JK
Int J Immunopharmacol; 1995 Jun; 17(6):513-6. PubMed ID: 7499028
[TBL] [Abstract][Full Text] [Related]
15. Peri-operative acute phase response and cytokine releasein women with breast cancer: modulation bypolyadenylic-polyuridylic acid.
Khan AL; Larsen F; Heys SD; Eremin O
Eur J Surg Oncol; 1999 Dec; 25(6):574-9. PubMed ID: 10556002
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant treatment with chemotherapeutic agents and polyadenylic-polyuridylic acid in operable stomach cancers. I. Enhancement of natural killer cell activity.
Youn JK; Kim BS; Min JS; Choi HJ; Lee YB; Lee DW; Koh EH; Kim KW; Lee KB; Michelson M
Yonsei Med J; 1985; 26(1):1-7. PubMed ID: 4072264
[No Abstract] [Full Text] [Related]
17. Abrogation of the tumor promoting effect of allogeneic blood transfusion by polyadenylic-polyuridylic acid (poly A-poly U).
Singh SK; Marquet RL; Westbroek DL; Jeekel J
Cancer Immunol Immunother; 1987; 25(3):242-4. PubMed ID: 3677125
[TBL] [Abstract][Full Text] [Related]
18. Polyadenylic.polyuridylic acid in the cotreatment of cancer.
Michelson AM; Lacour F; Lacour J
Proc Soc Exp Biol Med; 1985 May; 179(1):1-8. PubMed ID: 2581264
[TBL] [Abstract][Full Text] [Related]
19. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
Youn JK; Lacour F; Hue G
Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
